The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,4-bis(benzimidazole-2-ylmethyl)-1,4,7-triazacyclonone ID: ALA433982
PubChem CID: 11372706
Max Phase: Preclinical
Molecular Formula: C22H27N7
Molecular Weight: 389.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc2[nH]c(CN3CCNCCN(Cc4nc5ccccc5[nH]4)CC3)nc2c1
Standard InChI: InChI=1S/C22H27N7/c1-2-6-18-17(5-1)24-21(25-18)15-28-11-9-23-10-12-29(14-13-28)16-22-26-19-7-3-4-8-20(19)27-22/h1-8,23H,9-16H2,(H,24,25)(H,26,27)
Standard InChI Key: DKBVDTXZASJGTI-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
-3.0500 -0.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9750 0.5125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2375 -0.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2250 -0.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0625 -0.2750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9708 0.4958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3083 0.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6500 1.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 0.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6375 0.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0000 -0.9917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0333 -1.0250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8250 -0.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8125 -1.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.5250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7125 -0.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5875 -0.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1417 -1.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1708 -1.7917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8250 -2.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8250 -2.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0625 0.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7375 1.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0750 0.8583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7250 1.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4833 2.1458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1583 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1625 1.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4917 2.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 13 1 0
4 1 2 0
5 3 1 0
6 4 1 0
7 1 1 0
8 2 1 0
9 5 1 0
10 7 1 0
11 17 1 0
12 14 1 0
13 11 1 0
14 4 1 0
15 21 1 0
16 12 1 0
17 16 1 0
18 11 1 0
19 12 1 0
20 15 1 0
21 19 1 0
22 7 2 0
23 8 2 0
24 9 2 0
25 10 2 0
26 27 2 0
27 22 1 0
28 24 1 0
29 23 1 0
10 6 1 0
26 25 1 0
20 18 1 0
8 9 1 0
29 28 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.51Molecular Weight (Monoisotopic): 389.2328AlogP: 2.35#Rotatable Bonds: 4Polar Surface Area: 75.87Molecular Species: BASEHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.19CX Basic pKa: 9.59CX LogP: 1.67CX LogD: -0.33Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.06
References 1. Ji HF, Zhang HY.. (2005) A new strategy to combat Alzheimer's disease. Combining radical-scavenging potential with metal-protein-attenuating ability in one molecule., 15 (1): [PMID:15582403 ] [10.1016/j.bmcl.2004.10.047 ]